CYCLAFEM 7/7/7 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cyclafem 7/7/7, and when can generic versions of Cyclafem 7/7/7 launch?
Cyclafem 7/7/7 is a drug marketed by Vintage Pharms Llc and is included in one NDA.
The generic ingredient in CYCLAFEM 7/7/7 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for CYCLAFEM 7/7/7
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 7 |
Patent Applications: | 131 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CYCLAFEM 7/7/7 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CYCLAFEM 7/7/7
US Patents and Regulatory Information for CYCLAFEM 7/7/7
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vintage Pharms Llc | CYCLAFEM 7/7/7 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 076338-001 | Nov 16, 2010 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |